Asia Pacific Insulin Pump Market Outlook, Size, Share, Growth Insights, and Forecast 2032

The Asia Pacific insulin pump market is projected to grow from $4.60 billion in 2022 to $15.51 billion by 2030, with a CAGR of 20.0%. The market analysis covers China, India, Australia, Japan, Southeast Asia, and other Asia Pacific regions.

Key developments include:

• March 2022: Launch of Medtronic's MiniMed 780G system in India
• November 2022: Australian government subsidized Omnipod insulin pumps for 130,000 Type 1 diabetes patients
• October 2021: EOFlow and Sinocare formed SINOFLOW joint venture for Chinese market entry

Major market players include Medtronic, Insulet Corporation, and Tandem Diabetes Care. The market in developing countries faces growth challenges due to limited reimbursement policies, although government initiatives for diabetes care are creating new opportunities. For example, China reported only 15.2% of type 1 diabetes patients using insulin pump therapy as of 2021.

The report segments the market by:

• Type: Pumps and Consumables
• Distribution Channels: Hospital Pharmacies, Retail & Online Pharmacies
• Countries: Detailed analysis of China, India, Japan, Australia, Southeast Asia regions

Footnotes

Fortune Business Insights - Asia Pacific Insulin Pump Market Size | Analysis Report 2030

https://www.fortunebusinessinsights.com/asia-pacific-insulin-pump-market-107537